Eligi
Med
Ensayos clínicos
Suscripción
Sobre EligiMed
Ensayos Clínicos de Endocrinología | EligiMed
Ensayos clínicos
8.676 ensayos encontrados
Completado
Fase 2
ClinicalTrials.gov
An Open Label, Stratified, Single-arm Phase II Study of Everolimus in Patients With Advanced Pancreatic Neuroendocrine Tumor (NET) After Failure of Cytotoxic Chemotherapy
INTERVENTIONAL
Inicio: 1 de jun de 2006
ID: NCT00363051
Completado
Fase 3
ClinicalTrials.gov
A Multicenter, Randomized, Blinded Study to Assess Safety and Efficacy of Pasireotide LAR vs. Octreotide LAR in Patients With Active Acromegaly
INTERVENTIONAL
Inicio: 11 de feb de 2008
ID: NCT00600886
Completado
Fase 2
ClinicalTrials.gov
A Phase 2, Parallel-Group, Double-Blind Study to Investigate Weight Management With LY3841136 Compared With Placebo in Adult Participants With Obesity or Overweight
INTERVENTIONAL
Inicio: 5 de feb de 2024
ID: NCT06230523
Completado
Fase 4
ClinicalTrials.gov
Aspirin Statins Or Both For The Reduction Of Thrombin Generation In Diabetic People
INTERVENTIONAL
Inicio: 1 de mar de 2009
ID: NCT00793754
Completado
Fase 3
ClinicalTrials.gov
A Phase III, Multicenter, Randomized, Parallel-group Study to Assess the Efficacy and Safety of Double-blind Pasireotide LAR 40 mg and Pasireotide LAR 60 mg Versus Open-label Octreotide LAR or Lanreotide ATG in Patients With Inadequately Controlled Acromegaly
INTERVENTIONAL
Inicio: 19 de jul de 2010
ID: NCT01137682
Activo, no recluta
Fase 2
ClinicalTrials.gov
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multi-Center Phase 2 Study to Evaluate the Efficacy, Safety, and Tolerability of Once-Weekly CT-388 Administered Subcutaneously for 48 Weeks to Participants Who Are Overweight or Obese With Type 2 Diabetes Mellitus
INTERVENTIONAL
Inicio: 21 de nov de 2024
ID: NCT06628362
Completado
Fase 4
ClinicalTrials.gov
A 20 Week Randomised, Multinational, Open Labelled, 2 Armed, Parallel Group Comparison of Twice Daily Subject Driven Titration of Biphasic Insulin Aspart (BIAsp) 30 Versus Twice Daily Investigator-driven Titration of Biphasic Insulin Aspart (BIAsp) 30 Both in Combination With Metformin in Subjects With Type 2 Diabetes Inadequately Controlled on Basal Insulin Analogues
INTERVENTIONAL
Inicio: 1 de sept de 2011
ID: NCT01427920
Completado
Fase 3
ClinicalTrials.gov
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Determine the Efficacy and Safety of SYR110322 (SYR-322) When Used in Combination With a Sulfonylurea in Subjects With Type 2 Diabetes
INTERVENTIONAL
Inicio: 1 de abr de 2006
ID: NCT00286468
Reclutando
Fase 3
ClinicalTrials.gov
A Master Protocol to Investigate the Efficacy and Safety of Orforglipron Once Daily in Participants With Hypertension and Obesity or Overweight: Randomized, Double-Blind, Placebo-Controlled Trials (ATTAIN-HYPERTENSION)
INTERVENTIONAL
Inicio: 30 de abr de 2025
ID: NCT06948422
Terminado
ClinicalTrials.gov
A Long-Term, Post-Treatment, Safety Follow-Up, Multi-Center Study in Patients With Type 2 Diabetes Mellitus From the GALLANT, GALLEX or ARMOR Studies.
OBSERVATIONAL
Inicio: 1 de sept de 2005
ID: NCT00255645
Completado
Fase 3
ClinicalTrials.gov
A Randomized, Open-Label, Parallel-Arm, Noninferiority Comparison of the Effects of Two Doses of LY2189265 and Insulin Glargine on Glycemic Control in Patients With Type 2 Diabetes on Stable Doses of Metformin and Glimepiride
INTERVENTIONAL
Inicio: 1 de feb de 2010
ID: NCT01075282
Completado
Fase 4
ClinicalTrials.gov
A Multicenter, Multinational, Prospective, Interventional, Single-arm, Phase IV Study Evaluating the Clinical Efficacy and Safety of 26 Weeks of Treatment With Insulin Glargine 300 U/mL (Gla-300) in Patients With Type 2 Diabetes Mellitus Uncontrolled on Basal Insulin
INTERVENTIONAL
Inicio: 18 de dic de 2018
ID: NCT03760991
Activo, no recluta
Fase 3
ClinicalTrials.gov
A Phase 3, Randomized, Multi-center, Open-label Study of Trastuzumab Deruxtecan (T-DXd) Versus Investigator's Choice Chemotherapy in HER2-Low, Hormone Receptor Positive Breast Cancer Patients Whose Disease Has Progressed on Endocrine Therapy in the Metastatic Setting (DESTINY-Breast06)
INTERVENTIONAL
Inicio: 24 de jul de 2020
ID: NCT04494425
Completado
Fase 3
ClinicalTrials.gov
Efficacy and Safety of Tirzepatide Once Weekly Versus Placebo for Maintenance of Weight Loss in Participants Without Type 2 Diabetes Who Have Obesity or Are Overweight With Weight-Related Comorbidities: A Randomized, Double-Blind, Placebo-Controlled Trial (SURMOUNT-4)
INTERVENTIONAL
Inicio: 29 de mar de 2021
ID: NCT04660643
Completado
Fase 3
ClinicalTrials.gov
A Phase IIIb Multicenter, Open-label, Single Arm Study to Evaluate the Efficacy and Safety of Pasireotide in Patients With Acromegaly Inadequately Controlled With First Generation Somatostatin Analogues
INTERVENTIONAL
Inicio: 31 de mar de 2015
ID: NCT02354508
Completado
Fase 3
ClinicalTrials.gov
Six-month, Randomized, Open-label, Parallel-group Comparison of the Insulin Analog SAR342434 to Humalog® in Adult Patients With Type 2 Diabetes Mellitus Also Using Insulin Glargine
INTERVENTIONAL
Inicio: 1 de ene de 2015
ID: NCT02294474
Completado
Fase 3
ClinicalTrials.gov
Efficacy and Long-term Safety of Oral Semaglutide Versus Sitagliptin in Subjects With Type 2 Diabetes
INTERVENTIONAL
Inicio: 15 de feb de 2016
ID: NCT02607865
Activo, no recluta
Fase 3
ClinicalTrials.gov
A Phase 3 Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy, Safety, and Tolerability of Maridebart Cafraglutide in Adult Participants Without Type 2 Diabetes Mellitus Who Have Obesity or Are Overweight
INTERVENTIONAL
Inicio: 12 de mar de 2025
ID: NCT06858839
Completado
Fase 3
ClinicalTrials.gov
A Phase 3, Randomized, Open-Label Trial Comparing Efficacy and Safety of Tirzepatide Versus Semaglutide Once Weekly as Add-on Therapy to Metformin in Patients With Type 2 Diabetes
INTERVENTIONAL
Inicio: 30 de jul de 2019
ID: NCT03987919
Completado
Fase 3
ClinicalTrials.gov
Efficacy and Safety of Semaglutide Once Weekly Versus Insulin Glargine Once Daily as Add on to Metformin With or Without Sulphonylurea in Insulin-naïve Subjects With Type 2 Diabetes
INTERVENTIONAL
Inicio: 4 de ago de 2014
ID: NCT02128932
Anterior
1
...
28
29
30
...
434
Siguiente
Filtros